New research published in Alzheimer’s & Dementia has found that blood-brain barrier function may differ in individuals with the APOE4 gene, a known genetic risk factor for Alzheimer’s disease.

A genetic variant previously associated with a dramatic increase in Alzheimer’s risk may protect against age- and disease-related cognitive decline, a study published in Nature Aging this week ...

A MULTINATIONAL cohort study of 4,592 individuals has revealed significant sex and ancestry-based differences in how the APOE-ε4 gene influences Alzheimer’s disease biomarkers, with women of African ...

However, Dr. Segil says there is an existing test for Alzheimer’s disease, called the APOE4 gene test or just APOE test. The apolipoprotein E (APOE) gene is a well-known gene that influences Alzheimer ...

Dr. Alissa Huhn, a carrier of the Alzheimer’s risk gene, offers personalized health strategies to prevent cognitive decline ...

However, Dr. Segil says there is an existing test for Alzheimer’s disease, called the APOE4 gene test or just APOE test. The apolipoprotein E (APOE) gene is a well-known gene that influences ...

Studies have suggested that APOE4-associated Alzheimer's is a distinct genetic form of the disease, characterised by early onset and rapid progression, with around 900,000 people homozygous ...